1Wickes BL, Mayorga ME, Edman U, et al. Dimorphism and haploid fruiting in Cryptococcus noeformans:association with the α-mating type[J].Proc Natl Acad Sci USA,1996,93(14):7327-7331.
2Odom A, Muir S, Lim E, et al. Calcineurin is required for virulence of Cryptococcus neoformans[ J ]. EMBO J, 1997,16(10) :2576-2589.
3McFadden DC, Casadevall A. Capsule and melanin synthesis in Cryptococcus neoformans[ J]. Meal Mycol, 2001,39[ Suppl 1 ] : 19-30.
4Buchanan KL, Murphy JW. What makes Cryptococcus neoformans a pathogen[J]? Emerg Infect Di, 1998,4(1) :71-83.
5Huffnagle GB, Boyd MB, Street NE, et al. IL-5 is required for eosinophil recruitment crystal deposition and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice ( C57BL/6 ) [ J ]. J Immunol, 1998, 160 ( 5 ) : 2393-2400.
6Murphy JW, Schafer F, Casadevall A, et al. Antigen-induced protective and nonprotective cell-mediated immune components against Cryptococcus neoformans[J]. Infect Immun, 1998,66(6) :2632-2639.
7Casadevall A, Cleare W, Feldmesser M, et al. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies[J]. Antimicrob Agents Chemother, 1998,42(6) : 1437-1446.
8Varki A. Sialic acids as lifands in recognition phenomena[ J ]. FASEB J, 1997,11 (4) :248-255.
9Chang YC, Kwon-Chung KJ. Isolation, characterization and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans [ J ] . J Baecteriol, 1999,181(18) :5636-5643.
10Feldmesser M, Kress Y, Novikoff P, et al. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection[J]. Infect Immun,2000,68(7) :4225-4237.
